---
category: news
title: "Galmed to employ OnKai's disruptive Artificial Intelligence (AI) in its Planned Phase 2a Clinical Trial in PSC"
excerpt: "OnKai's AI models redefine the methodologies and economics of clinical trials. TEL AVIV, Israel, July 10, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (\"Galmed\""
publishedDateTime: 2023-07-10T13:44:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
webUrl: "https://www.tmcnet.com/usubmit/-galmed-employ-onkais-disruptive-artificial-intelligence-ai-its-/2023/07/10/9844997.htm"
type: article
quality: 14
heat: 14
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "4TK2/R8TdFXBhzLdf0dPKLknnxfOXWsN0/XL9MYqKE75CzyLlgLcjQ2k2WnLslpnzGSRqH9gKMbmd/WfJJzOf+fW5KJ1rTj5eDa1JEdL+FTi7yWFoeunTeJDPsZb37BUtGhVFs8DNOMDffTffssUu1PUBsuTPgs0Cl6P2cxh3FZNdACVJdkXL1A2+ihCcqSEEWs+LhSBik2dOGCNMTNW1fTKZvDQR4FaLiAf0eST+ZspTyc92UxC76YCnMQ7+Qy3kVgRf6uRKiCOq2mstTs5iGwYX/Zv5TMCPkG1jS1T5nDmZvBcrNKjC5zJGNoQFii0/8OBep3AxpdRvCarianDdgwukaQXgAHAEITvSxl9MEQ=;ZdAM1ETKdUxkMw7btrFNzA=="
---

